We describe a case of an otherwise healthy 60-year-old female patient who presented 6 days after receipt of the second dose of the BNT162b2 mRNA COVID-19 (Pfizer/BioNTech) vaccine and was found to have upper extremity deep venous thrombosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969541 | PMC |
http://dx.doi.org/10.1002/ccr3.6012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!